VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,759,248 | -26.2% | 3,614,662 | 0.0% | 0.10% | -28.9% |
| Q2 2023 | $5,096,673 | -11.3% | 3,614,662 | 0.0% | 0.14% | -32.4% |
| Q1 2023 | $5,747,313 | +8.9% | 3,614,662 | 0.0% | 0.21% | -5.8% |
| Q4 2022 | $5,277,407 | -65.8% | 3,614,662 | 0.0% | 0.22% | -65.0% |
| Q3 2022 | $15,435,000 | +10.1% | 3,614,662 | 0.0% | 0.64% | -5.8% |
| Q2 2022 | $14,025,000 | -18.5% | 3,614,662 | 0.0% | 0.68% | -1.6% |
| Q1 2022 | $17,206,000 | +37.1% | 3,614,662 | +5.1% | 0.69% | +50.9% |
| Q4 2021 | $12,552,000 | -49.4% | 3,438,944 | +11.1% | 0.46% | -52.9% |
| Q3 2021 | $24,815,000 | -29.3% | 3,094,174 | 0.0% | 0.97% | -26.4% |
| Q2 2021 | $35,088,000 | +22.6% | 3,094,174 | 0.0% | 1.32% | +22.6% |
| Q1 2021 | $28,621,000 | – | 3,094,174 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $421,314 | 0.28% |
| BVF INC/IL | 3,614,662 | $5,277,407 | 0.22% |
| Samsara BioCapital, LLC | 689,709 | $1,006,975 | 0.22% |
| Rubric Capital Management LP | 1,330,983 | $1,943,235 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $52 | 0.02% |
| MAI Capital Management | 426,916 | $623,297 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $135,691 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $25,550 | 0.01% |
| RP Management, LLC | 3,700 | $5,402 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,019,080 | 0.01% |